Rhosin is primarily used in research and experimental settings to study cellular processes, particularly those involving the Rho family of GTPases. It is known to inhibit RhoA, a protein involved in regulating the actin cytoskeleton, cell motility, and cell division. By blocking RhoA activity, Rhosin helps researchers understand its role in various biological pathways and diseases, such as cancer, cardiovascular disorders, and neurological conditions. Additionally, it has potential applications in drug development, where targeting RhoA signaling could lead to new therapeutic strategies for conditions characterized by abnormal cell proliferation or migration. Its use in laboratory studies provides valuable insights into cellular mechanics and disease mechanisms.